期刊文献+

类风湿关节炎滑膜中巨噬细胞移动抑制因子的表达及意义 被引量:1

Expression and significance of macrophage migration inhibitory factor in rheumatoid arthritis synovial
下载PDF
导出
摘要 目的探索巨噬细胞移动抑制因子(MIF)在类风湿性关节炎中的作用。方法建立类风湿关节炎小鼠模型,分为生理盐水对照组、空载体对照组和MIF-siRNA转染组,各15只,分别予以处理;通过RT-PCR检测关节膜组织中MIF的表达情况;关节膜组织中的MIF、磷脂酶A2(PLA2)、环氧化酶2(COX2)、血管内皮生长因子(VEGF)等表达通过Western Blot检测。结果 MIF-siRNA能有效地降低关节膜组织中的MIF的表达,关节膜内的MIF、PLA2、COX2、VEGF均表达下降。结论 MIF-siRNA在类风湿性关节炎模型中能关闭细胞的MIF基因,有效阻断MIF mRNA和蛋白的表达,随之而来的是PLA2、COX2、VEGF的表达下调。 Objective The purpose of this study was to explore effect of macrophage migration inhibition factor in rheumatoid arthritis. Methods The mouse model of rheumatoid arthritis was used in this study. Groups were divided into saline control group, vector control group and MIF - siRNA transfeeted group. Expression of MIF mRNA in joint membrane tissue was detected by RT - PCR. Expression of MIF, PLA2, COX2 and VEGF in joint membrane tissue were detected by Western Blot analysis. Results MIF - siRNA can effectively reduce the expression of MIF in joint membrane tissue. Expression of MIF, PLA2, COX2 and VEGF in joint membrane tissue were decreased. Conclusion MIF - siRNA in rheu- matoid arthritis model can turn off MIF gene, effectively blocking MIF mRNA and protein expression, which can cause the expression of PLA2, COX2 and VEGF down -regulate.
出处 《临床和实验医学杂志》 2013年第9期651-653,共3页 Journal of Clinical and Experimental Medicine
基金 广东省科技计划项目资助(2012年广东省第三批-No.18)
关键词 类风湿性关节炎 巨噬细胞移动抑制因子 siRNA治疗 Rheumatoid Arthritis Macrophage migration inhibition factor siRNA treatment
  • 相关文献

参考文献11

  • 1Szekanecz Z, Koch AE. Macrophages and their products in rheumatoid arthritis[J]. Curr Opin Rheumatol, 2007,19(3) :289 -295.
  • 2de Bandt M, Fautrel B, Maillefert JF, et al. Determining a low disease activity threshold for decision to maintain disease - modifying antirheu- marie drugtreatment unchanged in rheumatoid arthritis patients [ J]. Ar- thrifts Res Ther, 2009,11(5) :R153.
  • 3Liu R, Xu N, Wang X, et al. Influence of MIF, CD40, and CD226 polyrnorphisms on risk of rheumatoid arthritis[J]. Mol Biol Rep, 2012,39(6) :6915 -6922.
  • 4Herrero LJ, Nelson M, Srikiatldaaehom A, et al. Critical role for macro- phage migration inhibitory factor (MIF) in Ross River virus - induced arthritis and myositis[J]. Proe Natl Aead Sei U S A, 2011,108(29) : 12048 - 11253.
  • 5Singh A, Leng L, Fan J, et al. Maerophage - derived, maemphage mi- gration inhibitory factor (MIF) is necessary to induce disease in the K,/ BxNsemm - induced model of arthritis[ J]. Rheumatol Int, 2013,17.
  • 6Llamas -Covarrubias MA, Valle Y, Navarro- Hemdndez RE, et al. Serum levels of macmphage migration inhibitory factor are associated with rheumatoid arthritis course [ J]. Rheumatol Int, 2012,32 ( 8 ) : 2307 - 2311.
  • 7Wakabayashi K, Otsuka K, Sato M, et al. Elevated serum levels of maemphage migration inhibitory factor and their significant correlation with rheumatoid vaseulitis disease activity[ J]. Mod Rheumatol, 2012, 22(1) :59 -65.
  • 8Kudrin A, Scott M, Martin S, et al. Human maerophage migration in- hibitory factor: a proven immunomodulatory eytokine [ J] ? J Biol Chem, 2006,281 (40) :29641 -29651.
  • 9Szekaneez Z, Besenyei T, Szentprtery A, et al. Angiogenesis and vaseu- logenesis in rheumatoid arthritis[ J]. Curr Opin Rheumatol, 2010,22 (3) :299 -306.
  • 10Morand EF, Leech M, Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atheresclerosis [ J ]. Nat Rev Drug Discov, 2006,5(5) :399-410.

同被引文献16

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部